Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more than those in other countries.

IPA and Ind-Ra say Trump's MFN-based drug pricing move will impact innovators more than Indian generics, with CDMO firms ...

By linking US drug prices to those paid in similar economies, order could alter how pharmaceutical companies price their ...